Enhancing cancer-supportive care through virtual reality: a policy brief

保存先:

書誌詳細
出版年:	Health Research Policy and Systems vol. 23 (2025), p. 1
第一著者:	Esmaeel Toni
その他の著者:	Ayatollahi, Haleh
出版事項:	Springer Nature B.V.
主題:	Reimbursement Software Medical education Anxiety Pain management Guidelines Training Collaboration Cancer therapies Funding Health care Medical personnel Cancer Oncology Secondary analysis Computer applications Policy making Research & development > R&D Grants Virtual reality Policies Patients Quality of life Technology adoption Technology Financial support Health services Well being Palliative care Professionals Adoption of innovations Systematic review Chemotherapy Emotional distress Facial expressions Treatment outcomes Clinical practice guidelines Psychological distress Integrated care Access Clinical outcomes Educational programs Social
オンライン･アクセス:	Citation/Abstract Full Text Full Text - PDF
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

その他の書誌記述
抄録:	BackgroundVirtual reality (VR) technology has been useful in enhancing cancer-supportive care by alleviating pain, anxiety and emotional distress. However, its integration into oncology faces multiple barriers, including limited funding, insufficient clinician training, accessibility challenges, absence of standard guidelines and reimbursement policies. This policy brief highlighted policy options needed for VR technology interventions in cancer-supportive care.MethodsThis policy brief was developed upon a previous systematic review that examined the role of VR in cancer-supportive care. To translate these findings into actionable recommendations, we conducted a secondary analysis of policy-related opportunities and challenges. The extracted evidence was synthesized to propose strategic policy options that facilitate VR adoption in oncology.ResultsA total of five key policy options were identified: (1) increasing funding for VR research and development, (2) training programs for healthcare professionals, (3) expanding patient access through financial support mechanisms, (4) establishing standard clinical guidelines and (5) developing reimbursement policies. These recommendations aim to bridge the gap between technological advancements and their practical implementation in cancer care.ConclusionsIntegrating VR into cancer-supportive care requires a coordinated effort among policymakers, healthcare institutions and technology developers. By implementing these evidence-based policy strategies, stakeholders can enhance patient access, improve clinical outcomes and ensure sustainable adoption of VR in oncology.
ISSN:	1478-4505
DOI:	10.1186/s12961-025-01332-w
ソース:	Political Science Database